BIAFVSPRME• 7 Days (Normalized)
BIAF vs PRME (bioAffinity Technologies Inc. vs Prime Medicine Inc.)
Showing Closing Date Range from Sep, 08 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BIAF Performance $6.36
-28.78%
bioAffinity Technologies Inc.
Normalized Baseline0.00%
PRME Performance $3.14
-11.8%
Prime Medicine Inc.
Normalized Baseline0.00%
Alpha Spread Margin PRME LEADS
-16.98%
PRME outperforming by 16.98%
BIAFPRME
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BIAF PRME
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(6 dates)
| Date | BIAF Price | BIAF Gain (%) | PRME Price | PRME Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $6.36 | -28.78% | $3.14 | -11.80% | -16.98% |
| Sep 14, 2026 | $7.93 | -11.20% | $3.18 | -10.67% | -0.53% |
| Sep 11, 2026 | $7.95 | -10.97% | $3.13 | -12.08% | +1.11% |
| Sep 10, 2026 | $9.39 | +5.15% | $3.35 | -5.90% | +11.05% |
| Sep 09, 2026 | $10.50 | +17.58% | $3.47 | -2.53% | +20.11% |
| Sep 08, 2026 | $8.93 | +0.00% | $3.56 | +0.00% | +0.00% |